Frost & Sullivan Applauds Bernoulli for Its Market-Leading Clinical Platform Enabling Secure, End-To-End Medical Device Connectivity

Bernoulli One™ offers unparalleled medical device integration for clinical surveillance, virtual ICU, alarm management, predictive analytics, and robust distribution capabilities
Frost & Sullivan
2016-04-11 21:00 1815

MOUNTAIN VIEW, Calif., April 11, 2016 /PRNewswire/ -- Based on its recent analysis of the medical device connectivity market, Frost & Sullivan recognizes Bernoulli with the 2016 North American Frost & Sullivan Award for Product Leadership. The Bernoulli One™ platform for secure, end-to-end medical device connectivity, which facilitates efficient handling of patient-generated data from disparate sources, is proving to be disruptive in the market. Having correctly identified the key complexities experienced by clinicians, Bernoulli's unique clinical platform and product portfolio focus on addressing the future needs of the medical device connectivity, clinical surveillance, and real-time patient care analytics segments.


"A comprehensive single clinical connectivity platform with multiple real-time applications for hospitals and health systems ensures tremendous flexibility among Bernoulli's users," said Frost & Sullivan Research Analyst Dinesh Kumar. "Healthcare providers that have deployed Bernoulli's enterprise connectivity solutions find them simple to use in both high- and low-acuity settings, as they offer a large set of validated device driver libraries for existing devices, and integrate seamlessly with hospital information technology [IT] systems. This makes them much more versatile than the traditional solutions available in the market."

The Bernoulli One product suite enables device data collection, aggregation, and distribution of patient-generated data (including alarms and waveforms) throughout the healthcare enterprise. At the same time, Bernoulli's medical device integration system, featuring plug-and-play connectivity for medical devices, provides elegant software and hardware components with user-friendly interfaces to allow hospital IT teams to efficiently work with all connected devices. Bernoulli's medical device connectivity and informatics systems have US Food and Drug Administration 510(K) clearance, which significantly reduces risk to healthcare providers.

"Clients have witnessed improvements in their operational efficiency standards in the area of high-acuity care as a result of Bernoulli's integrated connectivity product suite," confirmed Kumar. "The Bernoulli One platform offers robust clinical connectivity solutions for administering quality care and enabling better patient outcomes. Furthermore, its Virtual ICU solution, with remote monitoring capabilities for real-time, centralized surveillance of acute-care patients, provides the flexibility to overcome critical challenges, thus improving patient safety and operational excellence."

Bernoulli emphasizes customization of its solutions to suit individual end-user needs and preferences. The company builds and implements device drivers for any new or legacy device in just four to six weeks, allowing for quicker deployments. This ability, coupled with a robust clinical surveillance system, provides it with a competitive edge in the market. The company's partnerships with industry-leading electronic health record vendors, medical device original equipment manufacturers, and health independent software vendors prove its significance.

"As Bernoulli's product suite finds its place in the hospital environment, its post-sales service support value proposition is high for installed base customers," Kumar said. "Bernoulli's customer-centric attitude is the backbone of the company's overall success in the market and key to its expansion in the North American medical device connectivity market. The last three years have seen business grow steadily as prestigious healthcare institutions in North American implement Bernoulli products in their high-acuity care facilities."

With its strong overall performance, Bernoulli has earned Frost & Sullivan's 2016 Product Leadership Award. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Bernoulli

Based in Milford, CT, Bernoulli is a leader in real-time connected healthcare, with more than 1,200 installed, operational systems. Bernoulli One™, the company's flagship platform, is the market's only real-time, end-to-end, connected healthcare platform that combines comprehensive and vendor-agnostic medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution. Bernoulli One empowers clinicians with tools to drive better outcomes, improve the patient experience, and enhance provider workflow. In December 2015, Cardiopulmonary Corp. merged with Nuvon, a leader in medical device connectivity and integration, creating Bernoulli. For more information visit

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation


Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003

Photo -

Source: Frost & Sullivan
Related Links: